Quality assurance considerations in Cryptosporidium antibody tests [2] (multiple letters)

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 1, 2003, Pages 193-194

  Frost, Floyd ^b   Muller, Tim ^b   Kunde, Twila ^b   Craun, Gunther ^b   Priest, Jeffrey W ^b   Lammie, Patrick J ^b   Li, Anna ^a   Khan, Mohamad ^a   Ong, Corinne S ^a   Isaac Renton, Judith ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CRYPTOSPORIDIUM ANTIBODY; PROTOZOON ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; COST CONTROL; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LETTER; PRIORITY JOURNAL; QUALITY CONTROL;

ANIMALS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOBLOTTING; QUALITY ASSURANCE, HEALTH CARE; SEROLOGIC TESTS;

EID: 0037249654     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.1.193-194.2003     Document Type: Letter

References (0)